Form EFFECT Dermata Therapeutics,
| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | May 29, 2026 4:15 P.M. |
| Form: | S-3 | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Ballard Power announces results of 2026 Annual General Meeting of Shareholders
- TalentMotives Announces the Launch of ExecMQi, an AI Leadership Development Platform for Executive Performance Improvement
- 2026 World Cup: Global Health Leaders Demand FIFA End its Coca-Cola Partnership - Vital Strategies
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share